Komori

Corporate Governance Report 2026/09/02

Submitted a Corporate Governance Report dated 2 September 2026, updating the current governance structure and the status of compliance with each principle of the Corporate Governance Code. As a company with an Audit & Supervisory Committee, the Company has 2 outside directors, including 1 independent outside director.

Worth reading
56In focus
Scored from 4 of 5 sections
Direction
Neutral
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Definitive
How definitive the wording is.

Governance structure

Company with an Audit and Supervisory Committee
Controlling shareholder
The Company currently has no controlling shareholder.

When one company holds most of the voting rights, its wishes are more likely to prevail in management. How the interests of minority shareholders are protected is a key issue.

Number of independent officers1Number

This is the number of people reported to the exchange as independent officers. Whether someone is an outside officer and whether they qualify as independent are separate determinations.

Committee3
Audit & Supervisory Committee . No advisory committeessuch as a Nomination Committee or Compensation Committeehave been established.
Percentage of outside members 2 outside members out of 3 Audit & Supervisory Committee members; outside members account for 2/3
Policy on cross-shareholdings

The Company does not hold any shares as policy shareholdings.

Policy regarding shares of other companies held to maintain business relationships and for other purposes.

Takeover defenses

Not introduced (there are currently no plans to introduce any).

Pre-agreed countermeasures in preparation for an unsolicited takeover attempt.

Changes this time

No specific changes from the previous report are stated.

Governance structure
ItemDetails
Corporate Governance StructureCompany with an Audit and Supervisory Committee
Number of independent officers1
CommitteeAudit & Supervisory Committee (2 outside members out of 3 Audit & Supervisory Committee members; outside members account for 2/3). No advisory committees, such as a Nomination Committee or Compensation Committee, have been established.
Policy on cross-shareholdingsThe Company does not hold any shares as policy shareholdings.
Takeover defensesNot introduced (there are currently no plans to introduce any).
Controlling shareholderThe Company currently has no controlling shareholder.
Changes this timeNo specific changes from the previous report are stated.
Items this document does not state (1)
Number of directors

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

To describe the Company's initiatives and policies based on the Corporate Governance Code.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Corporate Governance Report 2026/09/02 | AFC-HD AMS Life Science Co.,Ltd. (2927) timely disclosure | Komori